Monsanto Scores 2nd Phila. Roundup Verdict, but Fails to Stop Impending Trial
A jury determined Wednesday that Monsanto's Roundup weedkiller was defective, but the defect did not cause plaintiff Ryan Young's non-Hodgkin lymphoma.
September 12, 2024 at 05:36 PM
3 minute read
Mass TortsWhat You Need to Know
- Monsanto won its second Philadelphia Roundup verdict Wednesday.
- The jury found that Roundup was defective but that the defect did not cause the plaintiff's injuries.
- Jury selection in Philadelphia's next Roundup trial is already underway.
Monsanto has secured its second Philadelphia Roundup verdict.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Related Stories
View AllLaw Firms Mentioned
Trending Stories
- 1BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 2First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4The Growing Tension—And Opportunity—in Big Law Nonequity Tiers
- 5The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250